Actively Recruiting
European Registry Study on Lymphatic Interventions
Led by Rigshospitalet, Denmark · Updated on 2026-01-21
500
Participants Needed
1
Research Sites
212 weeks
Total Duration
On this page
Sponsors
R
Rigshospitalet, Denmark
Lead Sponsor
U
UZ Leuven, Leuven, Belgium
Collaborating Sponsor
AI-Summary
What this Trial Is About
This European multicenter observational study aims to evaluate the real-world use, timing, and outcomes of lymphatic interventions in patients with congenital heart disease and/or primary lymphatic disorders. The study will examine the effectiveness of diagnostic imaging and interventional techniques, such as lymphatic embolization, in improving clinical symptoms, biomarkers, and fluid-related complications. The central question is whether early diagnosis and targeted intervention can lead to clinically meaningful improvements and reduced need for reintervention. Data collected retrospectively and prospectively from participating centers will help identify predictors of outcome, assess disease severity, and inform standardized diagnostic and therapeutic pathways across Europe.
CONDITIONS
Official Title
European Registry Study on Lymphatic Interventions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of any age with a confirmed central lymphatic disorder related to congenital heart disease or a primary lymphatic disorder verified by lymphatic diagnostics
- Patients who have undergone or are undergoing diagnostic lymphatic imaging and/or interventional procedures for their lymphatic disorder
- Patients who are receiving or have received conservative (non-interventional) management for their lymphatic disorder
You will not qualify if you...
- Patients with isolated peripheral lymphatic disorders not involving the central lymphatic system
- Patients with acute postoperative iatrogenic chylothorax lasting less than 3-4 weeks and not requiring intervention
- Patients without sufficient clinical documentation to confirm diagnosis, treatment, or follow-up
- Patients or legal guardians who decline to provide informed consent for prospective inclusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rigshospitalet, Copenhagen University Hospital
Copenhagen, Denmark, 2100
Actively Recruiting
Research Team
S
Sanam Safi-Rasmussen, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here